3-year, firm-fixed price (FFP) task order for professional and technical support services to support the FDA's center for devices and radiological health (cdrh), office of strategic partnerships and…
Active Awarded Last action
- Contract number
- 75F40126F19022
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $823,239
Award facts
- Contract value 33% obligated
-
- $823,239.20 Current, with exercised options
- $2,519,054.40 Potential, with all options
- Completion date 5% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a $2.52 million delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) joint venture, on August 27, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ for professional and technical support to the FDA's Center for Devices and Radiological Health, Office of Strategic Partnerships and Technology Innovation, and Office of Supply.
This is a three-year firm-fixed-price task order with an ultimate completion date of August 26, 2029. Place of performance is Silver Spring, MD. The order was issued under the competitive 8(a) set-aside.
Description
3-year, firm-fixed price (FFP) task order for professional and technical support services to support the FDA's center for devices and radiological health (cdrh), office of strategic partnerships and technology innovation (OST), office of supply
Quick answers
Who was awarded contract 75F40126F19022?
75F40126F19022 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on August 27, 2026.
How much is contract 75F40126F19022 worth?
The government has obligated $823,239 on 75F40126F19022. Its potential value, with all options, is $2,519,054.
Is contract 75F40126F19022 an order under another contract?
Yes. 75F40126F19022 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40126F19022 competed?
The extent of competition for 75F40126F19022 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award